Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_03123 |
| Species: | Mus musculus |
| Position : | chr2:123456678-123456750 |
| Year: | 2014 |
| Title: | A regulatory network controls nephrocan expression and midgut patterning |
| Genome Build: | mm10 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| Disease Name: | -- |
| PMID: | 25209250 |
| MONDO: | |
| Tissue: | Embryo |
| Tissue Ontology ID: | UBERON:0000922 |
| Cell Source: | P19 cells |
| CVCL ID: | CVCL_2151 |
| Cell Type: | embryonal carcinoma cell |
| Cell Ontology ID: | CL:0000031 |
| Experiment Type: | Enhancer activity assay, TF binding assay |
| High Throughput Method: | |
| Low Throughput Method: | Luciferase reporter assay, EMSA, RT-RT-qPCR |
| Target gene : | Nepn |
| TF name : | Sox17 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| Sox17 | Deactivation of the beta-catenin transactivating complex | reactome | 42 |
| Sox17 | Wnt signaling pathway | kegg | 135 |
| Sox17 | Hs_Endoderm_Differentiation_WP2853_88152 | wikipathways | 62 |
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_03233 | chr2:123454700-123457000 | Embryo | embryonic cell | -- |